Autoimmune hepatitis triggered by adalimumab and allergic reactions after various anti-TNFα therapy agents in a patient with rheumatoid arthritis

Isr Med Assoc J. 2015 Apr;17(4):256-8.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adalimumab
  • Adult
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antirheumatic Agents / administration & dosage
  • Antirheumatic Agents / adverse effects
  • Arthritis, Rheumatoid* / diagnosis
  • Arthritis, Rheumatoid* / drug therapy
  • Arthritis, Rheumatoid* / physiopathology
  • Drug Eruptions / etiology
  • Drug Monitoring
  • Etanercept
  • Female
  • Hepatitis, Autoimmune* / diagnosis
  • Hepatitis, Autoimmune* / etiology
  • Hepatitis, Autoimmune* / physiopathology
  • Hepatitis, Autoimmune* / therapy
  • Humans
  • Immunoglobulin G / administration & dosage
  • Immunoglobulin G / adverse effects*
  • Interleukin 1 Receptor Antagonist Protein / administration & dosage*
  • Liver / pathology
  • Liver Function Tests / methods
  • Receptors, Tumor Necrosis Factor / administration & dosage
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Immunoglobulin G
  • Interleukin 1 Receptor Antagonist Protein
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Adalimumab
  • Etanercept